PSNL
ANALYST COVERAGE12 analysts
BUY
+73.0%upside to target
L $9.00
Med $11.00consensus
H $13.00
Buy
1192%
Hold
18%
11 Buy (92%)1 Hold (8%)0 Sell (0%)
Full report →
PRICE
Prev Close
6.71
Open
6.52
Day Range6.32 – 6.59
6.32
6.59
52W Range3.84 – 11.50
3.84
11.50
33% of range
VOLUME & SIZE
Avg Volume
1.8M
FUNDAMENTALS
P/E Ratio
-6.2x
Not profitable
EPS (TTM)
Div Yield
No dividend
Beta
2.11
High vol
TECHNICAL
RSI (14)
52
Bullish momentum
Upcoming Events
EEarnings Report
Tomorrow
May 19
DEx-Dividend
In 88 days
Aug 14
PDividend Pay
In 94 days
Aug 20
Key MetricsTTM
Market Cap$564.80M
Revenue TTM$64.52M
Net Income TTM-$95.55M
Free Cash Flow-$84.65M
Gross Margin13.7%
Operating Margin-158.9%
Net Margin-148.1%
Return on Equity-43.5%
Return on Assets-29.4%
Debt / Equity0.12
Current Ratio6.61
EPS TTM$-0.92

PSNL News

About

personalis is a genome-scale diagnostics company with a mission to pioneer genome guided medicine. our priority is to obtain the most accurate genetic data from each sample, and then to draw the most reliable medically-focused conclusions from these. our tests are based on whole human genome and exome sequencing, conducted in our state-of-the art laboratory. we analyze results utilizing proprietary databases, advanced human reference sequences, and sophisticated algorithms. personalis genome services provides academic, pharmaceutical, and biotech researchers an accurate and comprehensive end-to-end human genome sequencing and analysis solution. our services support researchers engaging in large case-control and family-based genome studies of complex or mendelian diseases and traits, pharmacogenomics, and cancer.

Industry
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
CEO
John West
Euan A. Ashley DPHIL FRCPCo-Founder and Member of Clinical & Scientific Advisory Board
Michael SnyderCo-Founder and Member of Clinical & Scientific Advisory Board
Russ AltmanCo-Founder and Member of Clinical & Scientific Advisory Board
Richard ChenExecutive Vice President of R&D and Chief Medical Officer
Aaron L. TachibanaChief Financial Officer & Chief Operating Officer
Stephane MouradianSenior Vice President of Business Development
Stephen MooreSenior Vice President, Chief Legal Officer & Corporate Secretary
Ashish KheterpalSenior Vice President & Chief Information Officer
Christopher HallCEO & Director
Deepshikha BhandariSenior Vice President of Regulatory, Quality & Clinical Compliance
Christian HaudenschildSenior Vice President of Genomic Science